Does Cinnamon Reduce Visceral Fat?

Does cinnamon reduce visceral fat? It is a question many people ask when looking for natural ways to tackle the deep abdominal fat linked to serious health conditions. Cinnamon contains bioactive compounds such as cinnamaldehyde that have shown promise in laboratory studies, but the picture in human clinical trials is far less convincing. This article examines what visceral fat is, what the current evidence actually shows, how much cinnamon has been studied, and what risks you should be aware of before reaching for a supplement.

What is visceral fat and why does it matter for your health?

Visceral fat surrounds internal organs and raises risk of type 2 diabetes, cardiovascular disease and metabolic liver disease. NICE flags waist circumference above 88 cm in women and 102 cm in men as indicating substantially increased cardiometabolic risk.

Visceral fat is the metabolically active fat stored deep within the abdominal cavity, surrounding organs such as the liver, pancreas and intestines, and it carries greater health risks than subcutaneous fat stored just beneath the skin. Unlike the fat you can pinch at the waist, visceral fat is not visible from the outside, yet it is strongly associated with increased risk of type 2 diabetes, cardiovascular disease, metabolic dysfunction-associated steatotic liver disease (formerly known as non-alcoholic fatty liver disease) and certain cancers.^[8][9]

Visceral fat releases inflammatory chemicals called cytokines and free fatty acids directly into the portal circulation, which can impair insulin signalling and promote systemic inflammation.^[8][9] Waist circumference is used clinically as a proxy measure of visceral adiposity. NICE guidance identifies a waist circumference above 88 cm in women and above 102 cm in men as indicating substantially increased cardiometabolic risk.^[1] In addition, a waist-to-height ratio above 0.5 is recognised as a marker of increased health risk in adults, and lower thresholds apply for people of South Asian, Chinese, Japanese and other high-risk ethnic backgrounds, reflecting greater cardiometabolic risk at a given waist size.^[1][5] Your GP can assess your individual risk and arrange relevant checks such as blood pressure, HbA1c and lipid levels if you are concerned.

Visceral fat accumulates for a range of reasons, including a calorie surplus, physical inactivity, poor sleep, chronic stress and genetic predisposition. Importantly, it is also one of the first fat depots to respond to lifestyle change. Sustained calorie reduction and increased aerobic exercise have the strongest evidence for reducing visceral fat; improved sleep quality may also contribute, though the evidence for sleep as a standalone intervention is less established than for diet and physical activity. Understanding this context is important before evaluating whether any single dietary supplement, including cinnamon, can meaningfully contribute to its reduction.

Does cinnamon actually help reduce visceral fat?

Current evidence does not support cinnamon as an effective standalone treatment for reducing visceral fat. No major UK clinical body, including NICE or the NHS, recommends cinnamon supplementation for weight management or fat reduction.

Current evidence does not support cinnamon as an effective standalone treatment for reducing visceral fat in humans. While laboratory and animal studies have identified several mechanisms by which cinnamon compounds might theoretically influence fat metabolism, translating these findings into clinically meaningful fat loss in people has proved difficult.

Cinnamon contains bioactive compounds, most notably cinnamaldehyde and procyanidins, which have been shown in preclinical (cell and rodent) studies to activate thermogenic pathways in fat tissue, improve insulin sensitivity and reduce lipid accumulation. Cinnamaldehyde, for example, has been shown in adipocyte studies to stimulate expression of genes involved in thermogenesis.^[10] Improved insulin sensitivity is particularly relevant because insulin resistance is closely linked to visceral fat accumulation. These findings are preliminary and have not been replicated at a clinically meaningful scale in human trials.

No major UK clinical body, including NICE or the NHS, currently recommends cinnamon supplementation as a weight management or fat reduction strategy. For people concerned about visceral fat, evidence-based approaches remain dietary change and physical activity, with medical support sought where appropriate. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where clinically appropriate options can be discussed.

What does the clinical evidence say about cinnamon and body fat?

Clinical trials show mixed, modest results with no robust evidence of visceral fat reduction. Systematic reviews confirm cinnamon may marginally improve glycaemic markers, but evidence for a direct effect on body fat remains insufficient.

Clinical trials examining cinnamon and body composition have produced mixed and generally modest results, with no robust evidence specifically demonstrating a reduction in visceral fat. Several randomised controlled trials have investigated cinnamon supplementation in people with type 2 diabetes, metabolic syndrome or overweight, measuring outcomes such as fasting blood glucose, insulin sensitivity, body mass index and waist circumference.

A number of small trials have reported modest improvements in fasting glucose and insulin resistance with daily cinnamon supplementation, typically using doses of 1 g to 6 g per day over periods of 8 to 16 weeks.^[11][12] Some studies have noted small reductions in waist circumference, which is used as a proxy for visceral fat, but these changes have often been statistically marginal and have not been consistently replicated across trials. Effect sizes where reported have generally been small, and confidence intervals wide.

Systematic reviews and meta-analyses published in peer-reviewed journals have concluded that while cinnamon may have a modest beneficial effect on glycaemic markers, evidence for a direct effect on body fat, and visceral fat in particular, remains insufficient.^[11][12] Heterogeneity between studies, including differences in cinnamon type (Ceylon versus Cassia), dose, formulation, participant characteristics and duration, makes pooling results unreliable and limits the conclusions that can be drawn.

Many trials have been conducted in populations with pre-existing metabolic conditions, so findings may not generalise to otherwise healthy individuals. Waist circumference, the most commonly used anthropometric outcome in these trials, is a proxy measure; none of the published human trials have used imaging techniques such as MRI or CT to directly quantify visceral fat. The overall picture is one of biological plausibility but insufficient clinical evidence to recommend cinnamon as a fat-reduction intervention.

How much cinnamon would you need to take to see any effect?

No established therapeutic dose exists, as no regulatory body endorses cinnamon for visceral fat reduction. Research has used 1 g to 6 g per day, but no dose has been proven effective and coumarin safety limits may be exceeded at higher amounts.

No established therapeutic dose of cinnamon for visceral fat reduction exists, because no regulatory body or clinical guideline has endorsed cinnamon for this purpose. The doses used in clinical research have varied considerably, ranging from approximately 1 g to 6 g of cinnamon powder per day, often taken as a standardised extract in capsule form rather than as culinary cinnamon added to food.

For context, a level teaspoon of ground cinnamon weighs roughly 2 g to 3 g, so the quantities studied are broadly within the range achievable through diet. However, culinary use of cinnamon, for example sprinkled on porridge or added to cooking, is unlikely to deliver consistent, standardised quantities equivalent to those used in trials. Variability in spice potency, coumarin content and the form in which cinnamon is consumed means that food-grade use and a standardised supplement are not equivalent.

The type of cinnamon also matters. Most commercially available cinnamon in the UK is Cassia cinnamon (Cinnamomum cassia or Cinnamomum aromaticum), which contains higher levels of coumarin, a naturally occurring compound that can be harmful in large amounts. The European Food Safety Authority (EFSA) has established a tolerable daily intake for coumarin of 0.1 mg per kilogram of body weight per day. Cassia cinnamon can contain coumarin at levels that mean regular consumption at trial-like doses of 2 g to 6 g per day could exceed this limit in some individuals, particularly those of lower body weight. Ceylon cinnamon (Cinnamomum verum), sometimes called true cinnamon, contains much lower coumarin levels and is generally considered safer for regular use, though it is less widely available.

Given the absence of a proven effective dose and the lack of regulatory endorsement, anyone considering cinnamon supplements should discuss this with a healthcare professional, particularly if they have existing medical conditions or take regular medication.

Are there any risks or side effects of taking cinnamon supplements?

Cassia cinnamon supplements carry real risks including liver toxicity from coumarin, potential interactions with warfarin and diabetes medicines, and gastrointestinal side effects. Cinnamon in normal culinary quantities is generally safe for most people.

Cinnamon supplements carry real risks, particularly when taken in the higher doses used in research studies, and these should not be overlooked simply because cinnamon is a familiar food ingredient. The most significant concern relates to coumarin, a naturally occurring compound found in high concentrations in Cassia cinnamon, which is the variety most commonly sold in UK supermarkets and health food shops.

The EFSA has established a tolerable daily intake for coumarin of 0.1 mg per kilogram of body weight per day. Analytical studies have found coumarin content in Cassia cinnamon ranging from approximately 1 g to 12 g per kilogram of spice, though levels vary by source and batch.^[15] Regular consumption of Cassia cinnamon supplements at doses of 2 g to 6 g per day could exceed safe coumarin limits in some individuals. High coumarin intake has been associated with liver toxicity.^[15] People with pre-existing liver conditions are at particular risk and should avoid cinnamon supplements unless advised otherwise by a doctor.

If you develop symptoms that could suggest liver injury, including yellowing of the skin or whites of the eyes (jaundice), dark urine, pale stools or persistent itching, you should stop taking the supplement and seek medical advice promptly.

Other potential concerns include:

• Drug interactions: Cinnamon may interact with anticoagulants such as warfarin and with diabetes medications. Evidence for these interactions is largely based on case reports and theoretical mechanisms rather than controlled trials, but caution is warranted. People taking anticoagulants or blood glucose-lowering medicines should speak to their GP or pharmacist before using cinnamon supplements, as there is a theoretical risk of increased bleeding or hypoglycaemia.

• Allergic reactions: Skin and oral sensitivity reactions have been reported, particularly with topical or high-dose use.

• Gastrointestinal effects: Some people experience nausea, heartburn or diarrhoea with supplement doses.

• Pregnancy and breastfeeding: There is insufficient evidence on the safety of cinnamon supplements during pregnancy or breastfeeding. As a precaution, pregnant or breastfeeding women should avoid cinnamon supplements and seek advice from their midwife or GP before use.

Healthcare professionals and patients can report suspected adverse reactions to supplements via the MHRA Yellow Card scheme at yellowcard.^[16]mhra.gov.uk. Anyone taking prescribed medication, or who has liver, kidney or blood-clotting conditions, should speak to their GP before starting any cinnamon supplement. Cinnamon used in normal culinary quantities is generally considered safe for most people.

Scientific References

1. Overweight and obesity management – Identifying and assessing overweight, obesity and central adiposity (NG246).
2. Keep the size of your waist to less than half of your height – NICE recommends.
3. Calculate your waist to height ratio.
4. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value.
5. Appendix A1: Summary of evidence from surveillance (NG246/PH46).
6. Obesity, abdominal obesity, and adipose tissue depots in South Asians with specific reference to Asian Indians: Implications of New Obesity Guidelines.
7. Waist circumference versus BMI: A cross-sectional study comparing cardiometabolic risk association in the Nepalese Population.
8. Impact of visceral adipose tissue on liver metabolism. Part I: heterogeneity of adipose tissue and functional properties of visceral adipose tissue.
9. Molecular mechanism in the development of the complications associated with obesity – the physiological and pathological role of adipocytokines.
10. Assessment report on Cinnamomum verum J. S. Presl, cortex and corticis aetheroleum.
11. The impact of cinnamon on anthropometric indices and glycemic status in patients with type 2 diabetes: A systematic review and meta-analysis of clinical trials.
12. The effect of cinnamon supplementation on glycemic control in patients with type 2 diabetes mellitus: An updated systematic review and dose-response meta-analysis of randomized controlled trials.
13. Effect of cinnamon as a Chinese herbal medicine on markers of cardiovascular risk in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.
14. Selective SGLT2 inhibitors in MASLD/MASH: an outcome-specific systematic review and meta-analysis of hepatic and cardiometabolic outcomes.
15. Toxicology and risk assessment of coumarin: focus on human data.
16. Adverse reactions to drugs – BNF/NICE medicines guidance.

Frequently Asked Questions